| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b93c2aafeb1bcb1019daee345cc8f141 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
| filingDate |
2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d756b9e72242265c863da9888e8b1a9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_087a312fcc0fd9628ba7652ae4fb008c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c46d7aa70da18d277ce1e660edf6e00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0115f575ad5a8e8aa294356e4b075a83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f8d3efb249d27eaa91afd7addce34d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d2317d791370a1dfe693663f3e969fb |
| publicationDate |
2014-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-103030687-B |
| titleOfInvention |
Anti-inflammatory active peptide Hydrostatin-SN1 derived from Hydrophis cyanocinctus, coding gene thereof and application in pharmacy |
| abstract |
The invention belongs to the technical field of biomedicine. So far, no report on bioactive peptides of Hydrophis cyanocinctus exists. The invention provides an anti-inflammatory active peptide Hydrostatin-SN1 derived from Hydrophis cyanocinctus. The anti-inflammatory active peptide Hydrostatin-SN1 derived from Hydrophis cyanocinctus contains a protein having an amino acid sequence shown as SEQ ID NO.1. The invention further provides a coding gene of Hydrostatin-SN1 and the application of anti-inflammatory active peptide Hydrostatin-SN1 derived from Hydrophis cyanocinctus and coding gene thereof for preparing medicaments for treatment of TNF-alpha-related diseases. The TNF-alpha-related diseases may include rheumatoid arthritis, diabetes, coronary heart disease, sepsis, colonitis and other complicated inflammation or immunological diseases. The anti-inflammatory active peptide Hydrostatin-SN1 derived from Hydrophis cyanocinctus and coding gene thereof are significant in clinical applications. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107090023-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107090023-B |
| priorityDate |
2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |